Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Calgary

$34,000.00

Cellular Reprogramming using Pluripotent Stem Cell Derived Exosomes

FY 2024-25

Summary
OBJECTIVES. Using the mouse embryonic stem cell (mESC) model, we have identified a new approach to cellular fate reprogramming using exosomes. Exosome-mediated reprogramming (XRP) may revolutionize cell sourcing for tissue engineering. We propose to 1) optimize XRP by standardizing methods for deriving and isolating ESC exosomes with maximal reprogramming potential derived from stirred suspension bioreactors, and 2) develop a platform that promotes reprogramming and trans-differentiation by loading additional transcription factors (TFs) into exosomes. We will leverage our expertise in pluripotent stem cell manufacturing, cellular reprogramming, and genome engineering. INSIGHT. An early cellular reprogramming step involves mesenchymal to epithelial transition (MET) wherein substrate-dependent cells become adhesion-dependent. When we applied mESC exosomes onto fibroblasts, we observed morphological changes consistent with MET and induced pluripotent stem cell (iPSC) colony formation. Immunofluorescence microscopy confirmed the presence of E-cadherin, consistent with MET. However, Oct4 supplementation was necessary to promote stable iPSC colony formation and pluripotency. We hypothesize that ESC exosomes promote partial reprogramming or pre-iPSCs. and that miR-302a, present in mESC exosomes, may govern the partial reprogramming we observe. SCIENTIFIC APPROACH. Using prior NSERC funding, we recently demonstrated that bioreactor fluid shear promotes pluripotency by inducing non-canonical Wnt signalling. Since miR-302a is upregulated by ß-catenin, we hypothesize that exosomes derived from ESCs cultured in the bioreactor may be more effective at promoting cellular reprogramming. The first objective of this research program is to improve the efficiency of XRP by exploiting bioreactor fluid shear. Our second objective will develop a novel approach to load TFs into mESC exosomes to promote XRP trans-differentiation. Consistent with our hypothesis that ESC exosomes promote partial reprogramming, we can generate ectodermal (i.e., neural), mesodermal (i.e., cardiac) and endodermal (i.e., hepatic) cell types using specific differentiation cocktails. Much like Oct4 supplementation (above), we hypothesize that XRP trans-differentiation will be enabled by loading tissue specific TFs into exosomes. Our approach leverages two features (i.e., that heat shock proteins are rich in exosomes and sequester ERT2 fusion proteins) to load exosomes with ERT2-TFs to complete cellular reprogramming and/or trans-differentiation in the presence of tamoxifen. SIGNIFICANCE. XRP is a nascent disruptive platform technology that has the potential to simplify cellular reprogramming and trans-differentiation for basic research and application. By eliminating the need for viral vectors, XRP could democratize cellular reprogramming and trans-differentiation. Our use of bioreactors to scale the manufacture of exosomes from genetically modified ESCs will enable this vision.
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2022-03166
Name nom
Rancourt, Derrick
Department département
Biochemistry and Molecular Biology
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
34000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5105
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell differentiation
Research subject fr
Différenciation cellulaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Cellular Reprogramming using Pluripotent Stem Cell Derived Exosomes
Keywords
pluripotent stem cells; exosome; cellular reprogramming; mesenchymal epithelial transition; microrna; suspension bioreactor; exosome loading; transcription factors; estrogen responsive element; heat shock protein
Application summary
OBJECTIVES. Using the mouse embryonic stem cell (mESC) model, we have identified a new approach to cellular fate reprogramming using exosomes. Exosome-mediated reprogramming (XRP) may revolutionize cell sourcing for tissue engineering. We propose to 1) optimize XRP by standardizing methods for deriving and isolating ESC exosomes with maximal reprogramming potential derived from stirred suspension bioreactors, and 2) develop a platform that promotes reprogramming and trans-differentiation by loading additional transcription factors (TFs) into exosomes. We will leverage our expertise in pluripotent stem cell manufacturing, cellular reprogramming, and genome engineering. INSIGHT. An early cellular reprogramming step involves mesenchymal to epithelial transition (MET) wherein substrate-dependent cells become adhesion-dependent. When we applied mESC exosomes onto fibroblasts, we observed morphological changes consistent with MET and induced pluripotent stem cell (iPSC) colony formation. Immunofluorescence microscopy confirmed the presence of E-cadherin, consistent with MET. However, Oct4 supplementation was necessary to promote stable iPSC colony formation and pluripotency. We hypothesize that ESC exosomes promote partial reprogramming or pre-iPSCs. and that miR-302a, present in mESC exosomes, may govern the partial reprogramming we observe. SCIENTIFIC APPROACH. Using prior NSERC funding, we recently demonstrated that bioreactor fluid shear promotes pluripotency by inducing non-canonical Wnt signalling. Since miR-302a is upregulated by ß-catenin, we hypothesize that exosomes derived from ESCs cultured in the bioreactor may be more effective at promoting cellular reprogramming. The first objective of this research program is to improve the efficiency of XRP by exploiting bioreactor fluid shear. Our second objective will develop a novel approach to load TFs into mESC exosomes to promote XRP trans-differentiation. Consistent with our hypothesis that ESC exosomes promote partial reprogramming, we can generate ectodermal (i.e., neural), mesodermal (i.e., cardiac) and endodermal (i.e., hepatic) cell types using specific differentiation cocktails. Much like Oct4 supplementation (above), we hypothesize that XRP trans-differentiation will be enabled by loading tissue specific TFs into exosomes. Our approach leverages two features (i.e., that heat shock proteins are rich in exosomes and sequester ERT2 fusion proteins) to load exosomes with ERT2-TFs to complete cellular reprogramming and/or trans-differentiation in the presence of tamoxifen. SIGNIFICANCE. XRP is a nascent disruptive platform technology that has the potential to simplify cellular reprogramming and trans-differentiation for basic research and application. By eliminating the need for viral vectors, XRP could democratize cellular reprogramming and trans-differentiation. Our use of bioreactors to scale the manufacture of exosomes from genetically modified ESCs will enable this vision.